Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Li D, Misialek JR, Boerwinkle E, et al. "Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS)." Alzheimers Dement (Amst). 2016;3:73-82.
Li D, Misialek JR, Jing M, et al. "Plasma phospholipid very-long-chain SFAs in midlife and 20-year cognitive change in the Atherosclerosis Risk in Communities (ARIC): a cohort study." Am J Clin Nutr. 2020;111(6):1252-1258.
Folsom AR, Ma J, Eckfeldt JH, Shahar E, Wu KK. "Plasma phospholipid fatty acid composition and factor VII coagulant activity." Atherosclerosis. 1994;111(2):199-207.
Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. "Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 2007;85(4):1103-11.
Li D, Misialek JR, Jack CR, et al. "Plasma Metabolites Associated with Brain MRI Measures of Neurodegeneration in Older Adults in the Atherosclerosis Risk in Communities⁻Neurocognitive Study (ARIC-NCS)." Int J Mol Sci. 2019;20(7).
Hoogeveen RC, Morrison A, Boerwinkle E, et al. "Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study." Atherosclerosis. 2005;183(2):301-7.
Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. "Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study." Kidney Int. 2000;58(1):293-301.
Shahar E, Chambless LE, Rosamond WD, et al. "Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2003;34(3):623-31.
Brown SA, Hutchinson R, Morrisett J, et al. "Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb. 1993;13(8):1139-58.
Juraschek SP, Bower JK, Selvin E, Shantha GPalamaner, Hoogeveen RC, Ballantyne CM. "Plasma lactate and incident hypertension in the atherosclerosis risk in communities study." Am J Hypertens. 2015;28(2):216-24.
Juraschek SP, Selvin E, Miller ER, Brancati FL. "Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study." Ann Epidemiol. 2013;23(12):791-796.e4.
Voight BF, Peloso GM, Orho-Melander M, et al. "Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study." Lancet. 2012;380(9841):572-80.
Rebholz CM, Selvin E, Liang M, et al. "Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease." Kidney Int. 2018;93(1):252-259.
Oyenuga A, Folsom AR, Fashanu O, Aguilar D. "Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study." Angiology. 2019;70(1):47-55.
Iso H, Folsom AR, Sato S, et al. "Plasma fibrinogen and its correlates in Japanese and US population samples." Arterioscler Thromb. 1993;13(6):783-90.
Folsom AR, Peacock JM, Nieto FJ, et al. "Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study." J Hypertens. 1998;16(11):1579-83.
Ma J, Folsom AR, Shahar E, Eckfeldt JH. "Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Am J Clin Nutr. 1995;62(3):564-71.
Yamagishi K, Folsom AR. "Plasma fatty acid composition and incident ischemic stroke in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Cerebrovasc Dis. 2013;36(1):38-46.
Yamagishi K, Nettleton JA, Folsom AR. "Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Am Heart J. 2008;156(5):965-74.
Wang L, Folsom AR, Zheng Z-jie, Pankow JS, Eckfeldt JH. "Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2003;78(1):91-8.
Wang L, Folsom AR, Eckfeldt JH. "Plasma fatty acid composition and incidence of coronary heart disease in middle aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Nutr Metab Cardiovasc Dis. 2003;13(5):256-66.
Zheng ZJ, Folsom AR, Ma J, Arnett DK, McGovern PG, Eckfeldt JH. "Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Epidemiol. 1999;150(5):492-500.
Jia X, Sun C, Tang O, et al. "Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women." J Clin Endocrinol Metab. 2020;105(12).
Folsom AR, Gottesman RF, Appiah D, Shahar E. "Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study." Stroke. 2016;47(1):18-23.
Prizment AE, Folsom AR, Dreyfus J, et al. "Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study." Cancer Causes Control. 2013;24(12):2077-87.
Folsom AR, Tang W, Basu S, Misialek JR, Couper DJ, Heckbert SR. "Plasma Concentrations of High Molecular Weight Kininogen and Prekallikrein and Venous Thromboembolism Incidence in the General Population." Thromb Haemost. 2019;119(5):834-843.
Damotte V, van der Lee SJ, Chouraki V, et al. "Plasma amyloid β levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants." Alzheimers Dement. 2021.
Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Coresh JJ. "Plant-Based Diets Are Associated With a Lower Risk of Incident Cardiovascular Disease, Cardiovascular Disease Mortality, and All-Cause Mortality in a General Population of Middle-Aged Adults." J Am Heart Assoc. 2019;8(16):e012865.
Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Grams ME, Coresh JJ. "Plant-Based Diets and Incident CKD and Kidney Function." Clin J Am Soc Nephrol. 2019;14(5):682-691.
Giri TK, Tollefsen DM. "Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II." Blood. 2006;107(7):2753-8.
Burke BTeevan, Köttgen A, Law A, et al. "Physical Function, Hyperuricemia, and Gout in Older Adults." Arthritis Care Res (Hoboken). 2015;67(12):1730-8.
Xu J, Liu G, Hegde SM, et al. "Physical Activity-Related Metabolites Are Associated with Mortality: Findings from the Atherosclerosis Risk in Communities (ARIC) Study." Metabolites. 2021;11(1).
Chin K, Zhao D, Tibuakuu M, et al. "Physical Activity, Vitamin D, and Incident Atherosclerotic Cardiovascular Disease in Whites and Blacks: The ARIC Study." J Clin Endocrinol Metab. 2017;102(4):1227-1236.
Gabriel KPettee, Griswold ME, Wang W, et al. "Physical activity trajectories and subsequent fall risk: ARIC Study." Prev Med. 2019;121:40-46.
Florido R, Zhao D, Ndumele CE, et al. "Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2016;5(9).
Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LYee. "Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study." Circ Arrhythm Electrophysiol. 2014;7(4):620-5.
Florido R, Ndumele CE, Kwak L, et al. "Physical Activity, Obesity, and Subclinical Myocardial Damage." JACC Heart Fail. 2017;5(5):377-384.
Lu Y, Ballew SH, Kwak L, et al. "Physical Activity and Subsequent Risk of Hospitalization With Peripheral Artery Disease and Critical Limb Ischemia in the ARIC Study." J Am Heart Assoc. 2019;8(21):e013534.
Dubbert PM, Penman AD, Evenson KR, Reeves RR, Mosley TH. "Physical activity and subclinical MRI cerebral infarcts: the ARIC Study." J Neurol Sci. 2009;284(1-2):135-9.
Kubota Y, Evenson KR, Maclehose RF, Roetker NS, Joshu CE. "Physical Activity and Lifetime Risk of Cardiovascular Disease and Cancer." Med Sci Sports Exerc. 2017;49(8):1599-1605.
Evenson KR, Rosamond WD, Cai J, et al. "Physical activity and ischemic stroke risk. The atherosclerosis risk in communities study." Stroke. 1999;30(7):1333-9.
Pereira MA, Folsom AR, McGovern PG, et al. "Physical activity and incident hypertension in black and white adults: the Atherosclerosis Risk in Communities Study." Prev Med. 1999;28(3):304-12.
Florido R, Kwak L, Lazo M, et al. "Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study." J Am Heart Assoc. 2020;9(10):e014885.
Folsom AR, Arnett DK, Hutchinson RG, Liao F, Clegg LX, Cooper LS. "Physical activity and incidence of coronary heart disease in middle-aged women and men." Med Sci Sports Exerc. 1997;29(7):901-9.
Bell EJ, Lutsey PL, Windham BG, Folsom AR. "Physical activity and cardiovascular disease in African Americans in Atherosclerosis Risk in Communities." Med Sci Sports Exerc. 2013;45(5):901-7.
Mertens AJ, Sweeney C, Shahar E, Rosamond WD, Folsom AR. "Physical activity and breast cancer incidence in middle-aged women: a prospective cohort study." Breast Cancer Res Treat. 2006;97(2):209-14.
Pendergrass SA, Buyske S, Jeff JM, et al. "A phenome-wide association study (PheWAS) in the Population Architecture using Genomics and Epidemiology (PAGE) study reveals potential pleiotropy in African Americans." PLoS One. 2019;14(12):e0226771.
Pendergrass SA, Brown-Gentry K, Dudek S, et al. "Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network." PLoS Genet. 2013;9(1):e1003087.
Seyerle AA, Sitlani CM, Noordam R, et al. "Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology." Pharmacogenomics J. 2018;18(2):215-226.
Floyd JS, Bloch KM, Brody JA, et al. "Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing." PLoS One. 2019;14(6):e0218115.
Postmus I, Trompet S, Deshmukh HA, et al. "Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins." Nat Commun. 2014;5:5068.
Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E. "Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 2008;87(6):1926-31.
Kalbaugh CA, Kucharska-Newton AMaria, Wruck L, et al. "Peripheral Artery Disease Prevalence and Incidence Estimated From Both Outpatient and Inpatient Settings Among Medicare Fee-for-Service Beneficiaries in the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2017;6(5).
Zhang S, Philips KH, Moss K, et al. "Periodontitis and Risk of Diabetes in the Atherosclerosis Risk In Communities (ARIC) Study: A BMI-modified Association." J Clin Endocrinol Metab. 2021.
Boillot A, Bouchard P, Moss K, Offenbacher S. "Periodontitis and retinal microcirculation in the Atherosclerosis Risk in Communities study." J Clin Periodontol. 2015;42(4):342-9.
Southerland JH, Moss K, Taylor GW, et al. "Periodontitis and diabetes associations with measures of atherosclerosis and CHD." Atherosclerosis. 2012;222(1):196-201.
Nakib SA, Pankow JS, Beck JD, et al. "Periodontitis and coronary artery calcification: the Atherosclerosis Risk in Communities (ARIC) study." J Periodontol. 2004;75(4):505-10.
Morelli T, Moss KL, Preisser JS, Beck JD, Divaris K, Wu D. "Periodontal profile classes predict periodontal disease progression and tooth loss." J Periodontol. 2018;89(2):148-156.
Beck JD, Moss KL, Morelli T. "Periodontal profile class is associated with prevalent diabetes, coronary heart disease, stroke, and systemic markers of C-reactive protein and interleukin-6." J Periodontol. 2018;89(2):157-165.
Philips KH, Zhang S, Moss K, Ciarrocca K, Beck JD. "Periodontal disease, undiagnosed diabetes, and body mass index: Implications for diabetes screening by dentists." J Am Dent Assoc. 2021;152(1):25-35.
Sen S, Giamberardino LD, Moss K, et al. "Periodontal Disease, Regular Dental Care Use, and Incident Ischemic Stroke." Stroke. 2018;49(2):355-362.
Arsiwala LT, Mok Y, Yang C, et al. "Periodontal disease measures and risk of incident peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study." J Periodontol. 2021.
Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ. "Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study." Am J Kidney Dis. 2005;45(4):650-7.
Beck JD, Philips K, Moss K, Sen S, Morelli T, Preisser J. "Periodontal disease classifications and incident coronary heart disease in the Atherosclerosis Risk in Communities study." J Periodontol. 2020;91(11):1409-1418.
Sen S, Redd K, Trivedi T, et al. "Periodontal Disease, Atrial Fibrillation and Stroke." Am Heart J. 2021;235:36-43.
Michaud DS, Lu J, Peacock-Villada AY, et al. "Periodontal Disease Assessed Using Clinical Dental Measurements and Cancer Risk in the ARIC Study." J Natl Cancer Inst. 2018;110(8):843-854.
Cowan LT, Lakshminarayan K, Lutsey PL, Folsom AR, Beck J, Offenbacher S. "Periodontal disease and incident venous thromboembolism: The Atherosclerosis Risk in Communities study." J Clin Periodontol. 2019;46(1):12-19.
Demmer RT, Norby FL, Lakshminarayan K, et al. "Periodontal disease and incident dementia: The Atherosclerosis Risk in Communities Study (ARIC)." Neurology. 2020;95(12):e1660-e1671.
Beck JD, Eke P, Heiss G, et al. "Periodontal disease and coronary heart disease: a reappraisal of the exposure." Circulation. 2005;112(1):19-24.
Pandey A, Mehta A, Paluch A, et al. "Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels." JAMA Cardiol. 2021;6(6):690-696.
Xing C, Dupuis J. "Performance of statistical methods on CHARGE targeted sequencing data." BMC Genet. 2014;15:104.
Jung M, Warren B, Grams M, et al. "Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study." J Diabetes. 2018;10(4):276-285.
Tang O, Daya N, Matsushita K, et al. "Performance of High-Sensitivity Cardiac Troponin Assays to Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes." Diabetes Care. 2020;43(6):1200-1208.
Liu X, Li C. "The performance of deleteriousness prediction scores for rare non-protein-changing single nucleotide variants in human genes." J Med Genet. 2017;54(2):134-144.
Patel MD, Rose KM, Owens CR, Bang H, Kaufman JS. "Performance of automated and manual coding systems for occupational data: a case study of historical records." Am J Ind Med. 2012;55(3):228-31.
Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. "Performance of A1C for the classification and prediction of diabetes." Diabetes Care. 2011;34(1):84-9.
Grams ME, Waikar SS, MacMahon B, Whelton S, Ballew SH. "Performance and limitations of administrative data in the identification of AKI." Clin J Am Soc Nephrol. 2014;9(4):682-9.
Lutsey PL, Folsom AR, Heckbert SR, Cushman M. "Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study." J Thromb Haemost. 2009;7(10):1639-48.
Armstrong NM, Wang H, E J-Y, et al. "Patterns of Prevalence of Multiple Sensory Impairments among Community-Dwelling Older Adults." J Gerontol A Biol Sci Med Sci. 2021.
Shahar E, Folsom AR, Romm FJ, et al. "Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study." Am Heart J. 1996;131(5):915-22.

Pages